ClinicalTrials.govpublic full text
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
neoplasm metastasis, tamk (tam kinase), mer (mer proto-oncogene), mertk (mer proto-oncogene tyrosine kinase), axl (axl receptor tyrosine kinase), axl/mer, selective kinase inhibitor, pd-1 (programmed cell death protein 1), pd-l1 (programmed cell death ligand 1), immune modulator, advanced cancer, metastatic cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 831965
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.